Sociodemographic and disease-related patient characteristics
| Sociodemographic characteristics | Initially adherent | Initially non-adherent | p Value | ||
|---|---|---|---|---|---|
| n | % | n | % | ||
| Classified age (years) | |||||
| ≤50 | 11 | 19.0 | 0 | 0.0 | 0.203 |
| 51–60 | 15 | 25.9 | 6 | 40.0 | |
| 61–70 | 17 | 29.3 | 3 | 20.0 | |
| 71–80 | 10 | 17.2 | 5 | 33.3 | |
| >80 | 5 | 8.6 | 1 | 6.7 | |
| Sex | |||||
| Female | 44 | 75.9 | 10 | 66.7 | 0.516 |
| Male | 14 | 24.1 | 5 | 33.3 | |
| Number of additional drugs (excluding PRN drugs) | |||||
| ≤5 | 45 | 77.6 | 10 | 66.7 | 0.514 |
| 6–10 | 9 | 15.5 | 3 | 20.0 | |
| >10 | 3 | 5.2 | 2 | 13.3 | |
| No answer | 1 | 1.7 | 0 | 0.0 | |
| Tumour entity | |||||
| Breast cancer | 21 | 36.2 | 7 | 46.7 | 0.818 |
| Colorectal cancer | 25 | 43.1 | 7 | 46.7 | |
| Gastric cancer | 3 | 5.2 | 0 | 0.0 | |
| Oesophageal cancer | 1 | 1.7 | 1 | 6.7 | |
| Ovarian cancer | 3 | 5.2 | 0 | 0.0 | |
| Cancer of unknown primary | 1 | 1.7 | 0 | 0.0 | |
| Pancreatic cancer | 3 | 5.2 | 0 | 0.0 | |
| Endometrial cancer | 1 | 1.7 | 0 | 0.0 | |
| Therapy regimen at inclusion | |||||
| Monotherapy | 35 | 60.3 | 7 | 46.7 | 0.339 |
| Combination therapy | 23 | 39.7 | 8 | 53.3 | |
| Treatment intention | |||||
| Curative | 8 | 13.8 | 3 | 20.0 | 0.686 |
| Palliative | 50 | 86.2 | 12 | 80.0 | |
| Classified time since diagnosis | |||||
| <½ year | 15 | 25.9 | 4 | 26.7 | 0.712 |
| ½ to 2 years | 22 | 37.9 | 4 | 26.7 | |
| >2 years | 21 | 36.2 | 7 | 46.7 | |
| Therapy setting | |||||
| Oncology outpatient ward | 51 | 87.9 | 9 | 60.0 | 0.021 |
| Oncology practice | 7 | 12.1 | 6 | 40.0 | |